IP Library › Granted Patent US 12,733,814
Granted Patent B2
US 12,733,814 · App. 17/714,643 · Granted Sep 15, 2026

Infrared otoscope for characterization of effusion

Inventors: Mark A. Moehring (Seattle, WA); George A. Gates (Boerne, TX); Daniel Kreindler (Foster City, CA); Jay A. Chesavage (Palo Alto, CA)
Assignee: OtoNexus Medical Technologies, Inc.
A61B5/0086A61B1/00009A61B1/00165A61B1/0638A61B1/0669A61B1/227A61B5/0066A61B5/12A61B5/14507A61B8/44G01B9/02091A61B1/0646A61B1/07G01J5/02G01J5/04G02B6/03694G02B23/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,733,814
App. No.
17/714,643
Granted
Sep 15, 2026
Kind
B2
Abstract

An otoscope uses differential reflected response of optical energy at an absorption range and an adjacent wavelength range to determine the presence of water (where the wavelengths are water absorption wavelength and adjacent non-absorption excitation wavelengths). In another example of the invention, the otoscope utilizes OCT in combination with absorption and non-absorption range for bacteria and water.

Claims (43)

1 . A method for diagnosing otitis media of a patient, the method comprising:

(a) directing a first optical energy along a measurement path, wherein the measurement path crosses a tympanic membrane and the first optical energy interacts with one or more of the tympanic membrane or a fluid adjacent the tympanic membrane;

(b) directing a second optical energy along a reference path;

(c) combining the first optical energy and the second optical energy at a detector after the first optical energy has interacted with the one or more of the tympanic membrane or the fluid adjacent the tympanic membrane and the first and second optical energies have traversed the measurement and reference paths, respectively, the combined first and second optical energies generating a detector response at the detector;

(d) comparing the detector response with a first contents of a template memory corresponding to an effusion fluid with a bacterial effusion, and comparing the detector response with a second contents of the template memory corresponding to the effusion fluid with a viral effusion, wherein the template memory stores one or more characteristics for a type of the effusion fluid; and

(e) characterizing the type of the effusion fluid, wherein the characterizing comprises distinguishing the type of the effusion fluid between the effusion fluid with the bacterial effusion and the effusion fluid with the viral effusion based on the one or more characteristics.

2 . The method of claim 1 , wherein the detector response comprises a wavelength dependent response.

3 . The method of claim 2 , further comprising comparing the wavelength dependent response to a template response of at least one known material, the template response being stored in the template memory.

4 . The method of claim 3 , wherein the template response comprises a template response of at least one of cerumen, healthy tympanic membrane, inflamed tympanic membrane, bacterial fluid, effusive fluid, or adhesive fluid.

5 . The method of claim 1 , further comprising indicating a presence of at least one of cerumen, healthy tympanic membrane, inflamed tympanic membrane, bacterial fluid, effusive fluid, or adhesive fluid to a user.

6 . The method of claim 1 , wherein the type of the effusion fluid comprises stored characteristics for a bacterial ear infection and a viral ear infection.

7 . The method of claim 1 , further comprising, before (a), directing a non-contact force through an air medium to one or more of a tympanic membrane or a fluid adjacent the tympanic membrane.

8 . The method of claim 7 , wherein the characterizing comprises determining a membrane metric from the detector response in response to the non-contact force.

9 . The method of claim 8 , wherein the membrane metric comprises at least one of an elasticity or a viscosity of the tympanic membrane or the fluid adjacent the tympanic membrane.

10 . The method of claim 9 , wherein the membrane metric is based on at least one of: a width of the detector response, a pedestal width of the detector response, or a reflected wavelength profile of the detector response.

11 . The method of claim 9 , wherein the non-contact force comprises an air puff or a pressure excitation.

12 . The method of claim 7 , wherein the non-contact force comprises an impulsive excitation.

13 . The method of claim 7 , wherein the non-contact force comprises a periodic excitation.

14 . The method of claim 13 , wherein a frequency of the periodic excitation is within a range from 20 Hz to 20 kHz.

15 . A system for diagnosing otitis media of a patient, the system comprising:

an interferometer configured to direct light energy along a reference path and a measurement path, wherein the measurement path comprises a tympanic membrane; and

a controller; and

a memory comprising a template memory storing one or more characteristics for a type of an effusion fluid, and wherein the memory is coupled to the controller and stores instructions for the controller to:

receive a detector signal from the interferometer,

compare the detector signal with a first contents of the template memory corresponding to the effusion fluid with a bacterial effusion, and compare the detector signal with a second contents of the template memory corresponding to the effusion fluid with a viral effusion, and

characterize the type of the effusion fluid, wherein the characterizing comprises distinguishing the type of the effusion fluid between the effusion fluid with the bacterial effusion and the effusion fluid with the viral effusion based on the one or more characteristics.

16 . The system of claim 15 , wherein the memory further stores instructions for the controller to determine a membrane metric in response to a non-contact force, and wherein the type of the effusion fluid is distinguished between one of the bacterial effusion and the viral effusion based on the membrane metric.

17 . The system of claim 16 , wherein the membrane metric comprises at least one of an elasticity or a viscosity of the tympanic membrane or a fluid adjacent the tympanic membrane.

18 . The system of claim 16 , wherein the membrane metric is based on at least one of: a detector response width, a pedestal width, or a reflected wavelength profile.

19 . The system of claim 15 , further comprising, an excitation generator configured to generate a non-contact force to be directed through an air medium to one or more of the tympanic membrane or the fluid adjacent the tympanic membrane.

20 . The system of claim 19 , wherein the non-contact force comprises an air puff or a pressure excitation.

21 . The system of claim 19 , wherein the interferometer comprises a light source.

22 . The system of claim 21 , wherein the light source comprises a light emitting diode.

23 . The system of claim 15 , wherein the interferometer comprises a broadband detector.

24 . The system of claim 23 , wherein the broadband detector is configured to generate a plurality of outputs, each output responsive to a unique range of wavelengths.

25 . The system of claim 15 , wherein the interferometer comprises a first splitter, which divides the light energy into the reference path and the measurement path, and a second splitter, which combines the reference path and the measurement path.

26 . The system of claim 25 , wherein the first splitter and second splitter comprise partially reflective mirrors.

27 . The system of claim 25 , wherein the first splitter and second splitter comprise optical fibers.

28 . The system of claim 15 , wherein a length of the reference path or a length of the measurement path is modulated using a voltage or current controlled actuator coupled to a mirror.

29 . The system of claim 15 , wherein a length of the reference path or a length of the measurement path is modulated using a PZT actuator coupled to an optical fiber.

30 . The system of claim 15 , wherein the template memory stores a template response of one of a plurality of known biological materials.

31 . The system of claim 30 , wherein the template response comprises one or more characteristics for at least one of cerumen, healthy tympanic membrane, inflamed tympanic membrane, bacterial fluid, effusive fluid, or adhesive fluid.

32 . The system of claim 14 , wherein the type of the effusion fluid comprises stored characteristics for a bacterial ear infection and a viral ear infection.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2022
From: CHESAVAGE, JAY; MOEHRING, MARK A.
To: OTONEXUS MEDICAL TECHNOLOGIES, INC.
Reel/Frame 059520/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2022
From: MOEHRING, MARK A.; GATES, GEORGE A.; KREINDLER, DANNY; SAVAGE, JAY A.
To: OTONEXUS MEDICAL TECHNOLOGIES, INC.
Reel/Frame 059520/0586 →
Continuity (5)
Continuation In Part 16438603 · Jun 12, 2019
Continuation 15609015 · May 31, 2017
Continuation In Part 16043584 · Jul 24, 2018
Continuation 15188750 · Jun 21, 2016
Related Publication 20220225881A1 · Jul 21, 2022
References Cited (95)
US 5115133A · Knudson et al. · 1992 [cited by applicant]
US 5321501A · Swanson et al. · 1994 [cited by applicant]
US 5383467A · Auer et al. · 1995 [cited by applicant]
US 6950692B2 · Gelikonov et al. · 2005 [cited by applicant]
US 7632232B2 · Lewandowski et al. · 2009 [cited by applicant]
US 7751057B2 · Oldenburg et al. · 2010 [cited by applicant]
US 8115934B2 · Boppart · 2012 [cited by examiner]
US 8594757B2 · Boppart et al. · 2013 [cited by applicant]
US 9014792B2 · Goldfain et al. · 2015 [cited by applicant]
US 9364148B2 · Roberts · 2016 [cited by applicant]
US 9638511B2 · Boppart et al. · 2017 [cited by applicant]
US 9788712B2 · Seth et al. · 2017 [cited by applicant]
US 9867528B1 · Boppart · 2018 [cited by examiner]
US 9918622B2 · Seth et al. · 2018 [cited by applicant]
US 10258238B2 · Boppart et al. · 2019 [cited by applicant]
US 10278570B2 · Shelton et al. · 2019 [cited by applicant]
US 10296780B2 · Karygianni et al. · 2019 [cited by applicant]
US 10327627B2 · Berkner et al. · 2019 [cited by applicant]
US 10357161B1 · Chesavage et al. · 2019 [cited by applicant]
US 10401141B2 · Boppart et al. · 2019 [cited by applicant]
US 10568515B2 · Moehring · 2020 [cited by examiner]
US 10660604B2 · Moehring et al. · 2020 [cited by applicant]
US 10709365B2 · Cohen et al. · 2020 [cited by applicant]
US 10772541B2 · Klein et al. · 2020 [cited by applicant]
US 11317811B2 · Moehring et al. · 2022 [cited by applicant]
US 11602275B2 · Moehring · 2023 [cited by examiner]
US 20020087084A1 · Shahar et al. · 2002 [cited by applicant]
US 20030171655A1 · Newman et al. · 2003 [cited by applicant]
US 20050059868A1 · Schurman · 2005 [cited by applicant]
US 20060229509A1 · Al-Ali et al. · 2006 [cited by applicant]
US 20060282009A1 · Oberg et al. · 2006 [cited by applicant]
US 20070112273A1 · Rogers · 2007 [cited by examiner]
US 20070129632A1 · Voie et al. · 2007 [cited by applicant]
US 20090037922A1 · Herington · 2009 [cited by applicant]
US 20090185191A1 · Boppart et al. · 2009 [cited by applicant]
US 20110286505A1 · Hedley et al. · 2011 [cited by applicant]
US 20130023914A1 · Truong et al. · 2013 [cited by applicant]
US 20130060131A1 · Oghalai · 2013 [cited by examiner]
US 20130165763A1 · Huang et al. · 2013 [cited by applicant]
US 20130289353A1 · Seth et al. · 2013 [cited by applicant]
US 20130342826A1 · Goldfain et al. · 2013 [cited by applicant]
US 20140206979A1 · Berkner et al. · 2014 [cited by applicant]
US 20140249426A1 · Huh et al. · 2014 [cited by applicant]
US 20140316278A1 · Addison et al. · 2014 [cited by applicant]
US 20150148654A1 · Whanwook et al. · 2015 [cited by applicant]
US 20150169435A1 · Wu et al. · 2015 [cited by applicant]
US 20150374208A1 · Ruppersberg et al. · 2015 [cited by applicant]
US 20160007840A1 · Boppart · 2016 [cited by examiner]
US 20160040978A1 · Boppart · 2016 [cited by examiner]
US 20170049309A1 · Lepple-Wienhues · 2017 [cited by applicant]
US 20180242847A1 · Boppart et al. · 2018 [cited by applicant]
US 20180256031A1 · Adamson et al. · 2018 [cited by applicant]
US 20180303348A1 · Boppart et al. · 2018 [cited by applicant]
US 20180353079A1 · Chesavage et al. · 2018 [cited by applicant]
US 20190142258A1 · Shelton et al. · 2019 [cited by applicant]
US 20190320887A1 · Shelton et al. · 2019 [cited by applicant]
US 20190343390A1 · Boppart et al. · 2019 [cited by applicant]
US 20190368929A1 · Zhang · 2019 [cited by examiner]
US 20220225881A1 · Moehring · 2022 [cited by examiner]
EP 3182886A4 · 2018 [cited by applicant]
EP 3641634A4 · 2021 [cited by applicant]
JP S55500123A · 1980 [cited by applicant]
JP S59500455A · 1984 [cited by applicant]
JP 2007500542A · 2007 [cited by applicant]
JP 2008531215A · 2008 [cited by applicant]
JP 2014519393A · 2014 [cited by applicant]
WO WO2013160780A4 · 2014 [cited by applicant]
WO WO2015169435A1 · 2015 [cited by applicant]
WO WO2016182999A1 · 2016 [cited by applicant]
WO WO2017222947A1 · 2017 [cited by applicant]
WO WO2018129430A1 · 2018 [cited by applicant]
WO WO2018160561A1 · 2018 [cited by applicant]
WO WO2018222782A1 · 2018 [cited by applicant]
Burkhardt et al. Investigation of the human tympanic membrane oscillation ex vivo by Doppler optical coherence tomography. J. Biophotonics 7, No. 6, 434-441 (2014). [cited by applicant]
Chang et al. Simultaneous 3D imaging of sound-induced motions of the tympanic membrane and middle ear ossicles. Hearing Research 304 (2013) 49-56. [cited by applicant]
EP20170815982.8 Summons to Attend Oral Proceedings dated Jan. 30, 2024. [cited by applicant]
U.S. Appl. No. 16/043,584 Notice of Allowance dated Nov. 9, 2022. [cited by applicant]
EP17815982.8 Extended Search Report dated Jan. 8, 2020. [cited by applicant]
EP18808827.2 European Search Report dated Sep. 29, 2020. [cited by applicant]
International search report with written opinion dated Aug. 7, 2018 for PCT/US2018/035228. [cited by applicant]
International search report with written opinion dated Oct. 24, 2017 for PCT/US2017/038052. [cited by applicant]
U.S. Appl. No. 15/188,750 Notice of Allowance dated Nov. 13, 2019. [cited by applicant]
Office action dated Mar. 7, 2019 for U.S. Appl. No. 15/188,750. [cited by applicant]
Sorrell et al., Bacteria Identification of Otitis Media with Fluorescence Spectroscopy, Lasers in Surgery and Medicine, 14:155-163 (1994). [cited by applicant]
Spector et al., Noninvasive Fluorescent Identification of Bacteria Causing Acute Otitis Media in a Chinchilla Model, The Laryngoscope, 110:1119-1123 (2000). [cited by applicant]
U.S. Appl. No. 15/609,015 Notice of Allowance dated Mar. 14, 2019. [cited by applicant]
U.S. Appl. No. 15/188,750 Office Action dated Mar. 7, 2019. [cited by applicant]
U.S. Appl. No. 15/609,015 Office Action dated Jul. 6, 2018. [cited by applicant]
U.S. Appl. No. 16/043,584 Office Action dated Dec. 18, 2020. [cited by applicant]
U.S. Appl. No. 16/043,584 Office Action dated Jul. 14, 2021. [cited by applicant]
U.S. Appl. No. 16/043,584 Office Action dated Mar. 16, 2021. [cited by applicant]
U.S. Appl. No. 16/043,584 Office Action dated Nov. 23, 2021. [cited by applicant]
U.S. Appl. No. 16/043,584 Office Action dated Sep. 18, 2020. [cited by applicant]
U.S. Appl. No. 16/438,603 Notice of Allowance dated Jan. 7, 2022. [cited by applicant]
U.S. Appl. No. 16/438,603 Office Action dated Mar. 30, 2021. [cited by applicant]